Discontinued lawsuit against Essity regarding bond loans

Essity announced that funds which sued the company in English courts over bond loans (including bonds maturing in 2029, 2030 and 2031) have discontinued their action following a conditional agreement that includes mutual releases related to Essity’s sale of its Vinda shares. The dispute originated after early redemption requests were received in October 2024 and proceedings were initiated in December 2024; Essity says it paid nothing and maintained the claim was unfounded. The discontinuation removes a legal overhang on the company and its longer-dated bonds, modestly reducing credit/legal risk for investors.

Analysis

Market structure: The discontinuation removes an idiosyncratic legal overhang on Essity (Essity Aktiebolag, STO: ESSITY B), likely tightening its credit spreads and modestly supporting equity sentiment within days. Direct winners are holders of Essity bonds and equity (reduced tail risk); marginal losers are the funds that pursued litigation. Pricing power and market share in hygiene are unchanged, but capital structure risk is lower, improving funding optionality over 12–24 months.

Risk assessment: Tail risks remain — plaintiffs could re-file in other jurisdictions or regulators could probe the Vinda sale; assign a low-probability ≈5–10% re-litigation risk over 12 months. Immediate (days) impact: muted positive repricing; short-term (weeks–months): CDS and bond spreads could compress 20–80bps; long-term (quarters) potential credit-rerating catalysts if cash proceeds/redeployment improve leverage by >0.2–0.4x net debt/EBITDA. Hidden dependency: covenant language tied to the Vinda sale may still create counterparty disputes for other creditors.

Trade implications: Credit is the primary alpha source — prefer buy-and-hold for 2029–2031 senior unsecured bonds if spreads exceed +175–200bps over swaps, targeting 50–150bps capital return as spreads normalize over 3–12 months. Equity trade: establish a tactical 2–3% long position in ESSITY B with a 3‑month target +8–12% and hard stop at −6%. Option strategy: sell ~3–5% notional 1y CDS protection or sell OTM 3‑month puts only if 5y CDS <120bps to harvest carry; alternatively, buy 3‑month ATM call spreads to lever upside with limited downside.

Contrarian angles: Consensus underestimates the signal value — clean legal resolution lowers cost of future divestitures/M&A and could unlock 0.1–0.3x enterprise value multiple expansion over 12–24 months. Reaction may be underdone: if rating agencies revise recovery assumptions modestly, bonds could tighten another 30–70bps. Watch for unintended consequences: aggressive share buybacks funded by Vinda proceeds could re-lever balance sheet and reverse credit gains.

Key Decisions for Investors

• Establish a 2–3% tactical long position in Essity (STO: ESSITY B) within 5 trading days; target +8–12% in 3 months, set stop-loss at −6% to capture near-term de‑risking.
• Buy Essity senior unsecured bonds maturing 2029–2031 if G-spread >175–200bps over swaps (or YTM offers >=100bps pickup vs peers); target 50–150bps capital gain as spreads normalize over 3–12 months, size 3–5% portfolio credit allocation.
• Sell (write) up to 25% notional of 5y CDS protection on Essity if 5y CDS trades above 120bps to collect carry, or alternatively sell 3‑month OTM puts on ESSITY B only if implied vol <20%; cap exposure to a max of 1–2% notional and hedge with bond holdings.
• Buy 3‑month ATM call spreads on ESSITY B to capture leveraged upside with defined risk (delta-equivalent 1–1.5% position), enter if implied vol > realized vol by 25–50bps; close on spread compression or upon bond spread tightening >50bps.